Drawing for HOPRUVI

USPTO serial 79279302

HOPRUVI

Reviewed by CopyMark Law Group

Status 401
Filing date
Status date
Registration date
—
Examiner
CARR, PATRICK C
Law office
TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HOPRUVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccinesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 29, 2020IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Apr 28, 2020IRRFIRREGULARITY ON REFUSAL FROM IB—
Apr 5, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 5, 2020RFRRREFUSAL PROCESSED BY MPU—
Apr 3, 2020DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 2, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2020DOCKASSIGNED TO EXAMINER—
Feb 29, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 20, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance